KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nu Skin Enterprises (NUS) EBITDA Margin (2016 - 2025)

Nu Skin Enterprises' EBITDA Margin history spans 17 years, with the latest figure at 6.28% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1819.0% year-over-year to 6.28%; the TTM value through Dec 2025 reached 4.43%, up 1318.0%, while the annual FY2025 figure was 4.43%, 1318.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 6.28% at Nu Skin Enterprises, up from 5.94% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 12.13% in Q2 2021 and bottomed at 28.6% in Q2 2024.
  • The 5-year median for EBITDA Margin is 4.75% (2022), against an average of 2.35%.
  • The largest annual shift saw EBITDA Margin tumbled -3709bps in 2024 before it surged 3657bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 3.02% in 2021, then skyrocketed by 74bps to 5.26% in 2022, then plummeted by -37bps to 3.29% in 2023, then plummeted by -462bps to 11.91% in 2024, then surged by 153bps to 6.28% in 2025.
  • Per Business Quant, the three most recent readings for NUS's EBITDA Margin are 6.28% (Q4 2025), 5.94% (Q3 2025), and 7.97% (Q2 2025).